Asked by: Lee Anderson (Reform UK - Ashfield)
Question to the HM Treasury:
To ask the Chancellor of the Exchequer, what recent assessment his Department has made of the potential impact of new regulatory costs, including new packaging costs, on pubs.
Answered by James Murray - Financial Secretary to the Treasury and Paymaster General
The potential impact of regulatory changes on pubs is carefully considered as part of policy development, and the Government regularly engages with the pub industry to understand the pressures businesses face. With regard to Extended Producer Responsibility for packaging, we are aware of concerns about the classification of packaging that is disposed of through commercial waste streams, including through pubs. We are working closely with stakeholders on this issue.
We are reducing unnecessary regulatory burdens and supporting pubs to grow. The National Licensing Policy Framework for England and Wales has set a new strategic direction for licensing authorities to have greater regard for growth when considering licensing applications and decisions. We also extended opening hours during the Men’s Football World Cup and are backing “pavement pints” by making it easier for hospitality businesses to serve food and drink outside.
Asked by: Lee Anderson (Reform UK - Ashfield)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps she is taking to improve (a) mental and (b) emotional support for people with brain tumours.
Answered by James Frith - Parliamentary Under-Secretary (Department of Health and Social Care)
The Hon. Member’s specific questions on gliomas and glioblastomas have been extensively dealt with in previous written answers, and I would refer him most recently to the answers of 3 March, 23 June, 29 June, 1 July, 15 July, 16 July and 20 July, in response to the respective Questions 115098, 9896, 10911, 11208, HL1675, HL1674, and HL1673.
More generally, through the National Cancer Plan, the Government is making rare cancers a priority. We have committed to being in the top quartile across 28 countries for survival of 14 less common cancers by 2035, including brain tumours, where survival rates currently rank 22nd out of 24 countries measured.
The Department recognises that general practitioners may rarely encounter specific rare cancers, which can make diagnosis more challenging. The plan includes measures to improve recognition and prevent missed diagnoses in primary care, including Jess's Rule, which supports clinicians to review and reconsider cases where symptoms remain unexplained or worsen over time.
Patients with rare cancers will also benefit from NHS England’s move to specialist multi-disciplinary teams that cover multiple providers. This will enable patients to benefit from the expertise of specialist centres and access the best evidence-based care. The Department and NHS England are working with rare cancer charities to strengthen support for patients, including providing guidance to clinical staff and connecting patients with specialist charities, peer communities, and expert sources of advice through the Diagnosis Connect Programme.
Asked by: Lee Anderson (Reform UK - Ashfield)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps her department is taking to ensure people can access effective treatment for brain tumours in NHS hospitals.
Answered by James Frith - Parliamentary Under-Secretary (Department of Health and Social Care)
The Hon. Member’s specific questions on gliomas and glioblastomas have been extensively dealt with in previous written answers, and I would refer him most recently to the answers of 3 March, 23 June, 29 June, 1 July, 15 July, 16 July and 20 July, in response to the respective Questions 115098, 9896, 10911, 11208, HL1675, HL1674, and HL1673.
More generally, through the National Cancer Plan, the Government is making rare cancers a priority. We have committed to being in the top quartile across 28 countries for survival of 14 less common cancers by 2035, including brain tumours, where survival rates currently rank 22nd out of 24 countries measured.
The Department recognises that general practitioners may rarely encounter specific rare cancers, which can make diagnosis more challenging. The plan includes measures to improve recognition and prevent missed diagnoses in primary care, including Jess's Rule, which supports clinicians to review and reconsider cases where symptoms remain unexplained or worsen over time.
Patients with rare cancers will also benefit from NHS England’s move to specialist multi-disciplinary teams that cover multiple providers. This will enable patients to benefit from the expertise of specialist centres and access the best evidence-based care. The Department and NHS England are working with rare cancer charities to strengthen support for patients, including providing guidance to clinical staff and connecting patients with specialist charities, peer communities, and expert sources of advice through the Diagnosis Connect Programme.
Asked by: Lee Anderson (Reform UK - Ashfield)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what recent assessment her department has made of the effectiveness of treatment offered in the UK for gliomas.
Answered by James Frith - Parliamentary Under-Secretary (Department of Health and Social Care)
The Hon. Member’s specific questions on gliomas and glioblastomas have been extensively dealt with in previous written answers, and I would refer him most recently to the answers of 3 March, 23 June, 29 June, 1 July, 15 July, 16 July and 20 July, in response to the respective Questions 115098, 9896, 10911, 11208, HL1675, HL1674, and HL1673.
More generally, through the National Cancer Plan, the Government is making rare cancers a priority. We have committed to being in the top quartile across 28 countries for survival of 14 less common cancers by 2035, including brain tumours, where survival rates currently rank 22nd out of 24 countries measured.
The Department recognises that general practitioners may rarely encounter specific rare cancers, which can make diagnosis more challenging. The plan includes measures to improve recognition and prevent missed diagnoses in primary care, including Jess's Rule, which supports clinicians to review and reconsider cases where symptoms remain unexplained or worsen over time.
Patients with rare cancers will also benefit from NHS England’s move to specialist multi-disciplinary teams that cover multiple providers. This will enable patients to benefit from the expertise of specialist centres and access the best evidence-based care. The Department and NHS England are working with rare cancer charities to strengthen support for patients, including providing guidance to clinical staff and connecting patients with specialist charities, peer communities, and expert sources of advice through the Diagnosis Connect Programme.
Asked by: Lee Anderson (Reform UK - Ashfield)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps she is taking to improve diagnosis (a) accuracy and (b) times for brain tumours.
Answered by James Frith - Parliamentary Under-Secretary (Department of Health and Social Care)
The Hon. Member’s specific questions on gliomas and glioblastomas have been extensively dealt with in previous written answers, and I would refer him most recently to the answers of 3 March, 23 June, 29 June, 1 July, 15 July, 16 July and 20 July, in response to the respective Questions 115098, 9896, 10911, 11208, HL1675, HL1674, and HL1673.
More generally, through the National Cancer Plan, the Government is making rare cancers a priority. We have committed to being in the top quartile across 28 countries for survival of 14 less common cancers by 2035, including brain tumours, where survival rates currently rank 22nd out of 24 countries measured.
The Department recognises that general practitioners may rarely encounter specific rare cancers, which can make diagnosis more challenging. The plan includes measures to improve recognition and prevent missed diagnoses in primary care, including Jess's Rule, which supports clinicians to review and reconsider cases where symptoms remain unexplained or worsen over time.
Patients with rare cancers will also benefit from NHS England’s move to specialist multi-disciplinary teams that cover multiple providers. This will enable patients to benefit from the expertise of specialist centres and access the best evidence-based care. The Department and NHS England are working with rare cancer charities to strengthen support for patients, including providing guidance to clinical staff and connecting patients with specialist charities, peer communities, and expert sources of advice through the Diagnosis Connect Programme.
Asked by: Lee Anderson (Reform UK - Ashfield)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps her department is taking to improve treatment for glioblastomas.
Answered by James Frith - Parliamentary Under-Secretary (Department of Health and Social Care)
The Hon. Member’s specific questions on gliomas and glioblastomas have been extensively dealt with in previous written answers, and I would refer him most recently to the answers of 3 March, 23 June, 29 June, 1 July, 15 July, 16 July and 20 July, in response to the respective Questions 115098, 9896, 10911, 11208, HL1675, HL1674, and HL1673.
More generally, through the National Cancer Plan, the Government is making rare cancers a priority. We have committed to being in the top quartile across 28 countries for survival of 14 less common cancers by 2035, including brain tumours, where survival rates currently rank 22nd out of 24 countries measured.
The Department recognises that general practitioners may rarely encounter specific rare cancers, which can make diagnosis more challenging. The plan includes measures to improve recognition and prevent missed diagnoses in primary care, including Jess's Rule, which supports clinicians to review and reconsider cases where symptoms remain unexplained or worsen over time.
Patients with rare cancers will also benefit from NHS England’s move to specialist multi-disciplinary teams that cover multiple providers. This will enable patients to benefit from the expertise of specialist centres and access the best evidence-based care. The Department and NHS England are working with rare cancer charities to strengthen support for patients, including providing guidance to clinical staff and connecting patients with specialist charities, peer communities, and expert sources of advice through the Diagnosis Connect Programme.
Asked by: Lee Anderson (Reform UK - Ashfield)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps her department is taking to support research into glioblastomas.
Answered by James Frith - Parliamentary Under-Secretary (Department of Health and Social Care)
The Hon. Member’s specific questions on gliomas and glioblastomas have been extensively dealt with in previous written answers, and I would refer him most recently to the answers of 3 March, 23 June, 29 June, 1 July, 15 July, 16 July and 20 July, in response to the respective Questions 115098, 9896, 10911, 11208, HL1675, HL1674, and HL1673.
More generally, through the National Cancer Plan, the Government is making rare cancers a priority. We have committed to being in the top quartile across 28 countries for survival of 14 less common cancers by 2035, including brain tumours, where survival rates currently rank 22nd out of 24 countries measured.
The Department recognises that general practitioners may rarely encounter specific rare cancers, which can make diagnosis more challenging. The plan includes measures to improve recognition and prevent missed diagnoses in primary care, including Jess's Rule, which supports clinicians to review and reconsider cases where symptoms remain unexplained or worsen over time.
Patients with rare cancers will also benefit from NHS England’s move to specialist multi-disciplinary teams that cover multiple providers. This will enable patients to benefit from the expertise of specialist centres and access the best evidence-based care. The Department and NHS England are working with rare cancer charities to strengthen support for patients, including providing guidance to clinical staff and connecting patients with specialist charities, peer communities, and expert sources of advice through the Diagnosis Connect Programme.
Asked by: Lee Anderson (Reform UK - Ashfield)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps her department is taking to increase awareness of the symptoms of gliomas.
Answered by James Frith - Parliamentary Under-Secretary (Department of Health and Social Care)
The Hon. Member’s specific questions on gliomas and glioblastomas have been extensively dealt with in previous written answers, and I would refer him most recently to the answers of 3 March, 23 June, 29 June, 1 July, 15 July, 16 July and 20 July, in response to the respective Questions 115098, 9896, 10911, 11208, HL1675, HL1674, and HL1673.
More generally, through the National Cancer Plan, the Government is making rare cancers a priority. We have committed to being in the top quartile across 28 countries for survival of 14 less common cancers by 2035, including brain tumours, where survival rates currently rank 22nd out of 24 countries measured.
The Department recognises that general practitioners may rarely encounter specific rare cancers, which can make diagnosis more challenging. The plan includes measures to improve recognition and prevent missed diagnoses in primary care, including Jess's Rule, which supports clinicians to review and reconsider cases where symptoms remain unexplained or worsen over time.
Patients with rare cancers will also benefit from NHS England’s move to specialist multi-disciplinary teams that cover multiple providers. This will enable patients to benefit from the expertise of specialist centres and access the best evidence-based care. The Department and NHS England are working with rare cancer charities to strengthen support for patients, including providing guidance to clinical staff and connecting patients with specialist charities, peer communities, and expert sources of advice through the Diagnosis Connect Programme.
Asked by: Lee Anderson (Reform UK - Ashfield)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps her Department is taking to tackle the rate of postpartum haemorrhage in Nottinghamshire.
Answered by Alison McGovern - Minister of State (Department of Health and Social Care)
Both Sherwood Forest Hospitals NHS Foundation Trust and Nottingham University Hospitals NHS Trust continue surveillance and governance oversight of severe postpartum haemorrhage (PPH), with serious cases reviewed through the Perinatal Safety Incident Review Group. They are embedding the practice of measuring rather than estimating blood loss to support earlier recognition and intervention, alongside other quality improvements.
Following the Ockenden Review, timely risk assessment, escalation and management of PPH are specific learning themes, supported by multidisciplinary education, training and guideline review. The Perinatal Quality Surveillance Group and the local Perinatal Partnership Group continue to oversee progress and seek assurance from both trusts.
Asked by: Lee Anderson (Reform UK - Ashfield)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what recent steps her department is taking to increase investment into palliative care.
Answered by Alison McGovern - Minister of State (Department of Health and Social Care)
I refer the Hon. Member to the answer given on 20 July to Question 18732, which sets out the Government's position on this matter.